Compare BVN & BTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BVN | BTG |
|---|---|---|
| Founded | 1953 | 2006 |
| Country | Peru | Canada |
| Employees | N/A | 6327 |
| Industry | Metal Mining | Precious Metals |
| Sector | Basic Materials | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 7.1B |
| IPO Year | 1997 | 2007 |
| Metric | BVN | BTG |
|---|---|---|
| Price | $33.87 | $5.35 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $44.00 | $6.00 |
| AVG Volume (30 Days) | 959.9K | ★ 26.7M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.78% | 1.86% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.99 | $38.08 |
| Revenue Next Year | N/A | $28.46 |
| P/E Ratio | ★ $21.78 | $34.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.55 | $3.57 |
| 52 Week High | $44.67 | $6.29 |
| Indicator | BVN | BTG |
|---|---|---|
| Relative Strength Index (RSI) | 49.44 | 53.37 |
| Support Level | $32.60 | $5.08 |
| Resistance Level | $36.66 | $5.88 |
| Average True Range (ATR) | 1.36 | 0.19 |
| MACD | -0.20 | -0.07 |
| Stochastic Oscillator | 17.39 | 19.01 |
Compania de Minas Buenaventura SAA is a Peruvian precious metals-producing company with experience in mine exploration, development, construction, and operation.
B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other assets include the Gramalote gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.